One course versus two courses of antithymocyte globulin for the treatment of severe aplastic anemia in children

American Journal of Pediatric Hematology/Oncology

Volumn 19, Issue 2, 1997, Pages 110-114

  Matloub, Yousif H ^a   Smith, C ^c   Bostrom, B ^c   Koerper, M A ^d   O'Leary M ^c   Khuder, S ^b   Smithson, W A ^e   Nickerson, H J ^f   Silberman, T ^f   Hilden, J ^c   Moertel, C L ^c   Month, S ^g   Monteleone, P ^h   Ramsay, N K C ⁱ  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b Department of Internal Medicine ^*  (United States)

^c Hematology and Oncology   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MAYO CLINIC   (United States)

^f MARSHFIELD CLINIC   (United States)

^g KAISER PERMANENTE   (United States)

^h BAYSTATE MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Anemia; Antithymocyte globulin; Aplasia; Aplastic anemia; Cyclosporine A

Indexed keywords

CYCLOSPORIN A; PREDNISONE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TREATMENT PLANNING;

ADOLESCENT; ANEMIA, APLASTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTILYMPHOCYTE SERUM; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; PREDNISONE;

EID: 0030943886     PISSN: 01928562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199703000-00003     Document Type: Article

References (20)

1. Alter BP, Potter NU, Li FP. Classification and aetiology of the aplastic anemias. Clinical Haematology 1978; 7: 431-65.
2. Camitta BM, Thomas ED, Nathan DG, et al. Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood 1976; 48: 63-70.
3. Camitta BM, Storb R, Thomas ED. Aplastic anemia; pathogenesis, diagnosis, treatment and prognosis. N Engl J Med 1982; 306: 712-8.
4. Bayever E, Champlin R, Ho W, et al. Comparison between bone marrow transplantation and antithymocyte globulin in treatment of young patients with severe aplastic anemia. J Pediatr 1984; 105: 920-5.
5. Doney K, Storb R, Buckner CD, et al. Treatment of aplastic anemia with antithymocyte globulin, high dose corticosteroids, and androgens. Exp Hematol 1987; 15: 239-42.
6. Paquette RL, Tebyani N, Frane M, et al. Long term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantation. Blood 1995; 85: 283-90.
7. McGlave PB, Haake R, Miller W, et al. Therapy of severe aplastic anemia in young adults and children with allogeneic bone marrow transplantation. Blood 1987; 70: 1325-30.
8. Champlin R, Ho W, Gale RP. Antithymocyte globulin treatment in patients with aplastic anemia; a prospective randomized trial. N Engl J Med 1983; 308: 113-8.
9. Matloub YH, Bostrom B, Golembe B, et al. Antithymocyte globulin, cyclosporine and prednisone for the treatment of severe aplastic anemia in children: a pilot study. Am J Pediatr Hematol Oncol 1994; 16: 104-6.
10. Sanders JE, Storb R, Anasetti C, et al. Marrow transplant experience for children with severe aplastic anemia. Am J Pediatr Hematol Oncol 1994; 16: 43-9.
11. Werner EJ, Stout RD, Valdez LP, et al. Immunosuppressive therapy versus bone marrow transplantation for children with aplastic anemia. Pediatrics 1989; 83: 61-5.
12. Facon T, Walter MP, Fenaux P, et al. Treatment of severe aplastic anemia with antilymphocyte globulin and androgens: a report on 33 patients. Ann Hematol 1991; 63: 89-93.
13. Camitta BM, Nathan DG, Forman EN, et al. Posthepatitis severe aplastic anemia-an indication for early bone marrow transplantation. Blood 1974; 43: 473-83.
14. Hagler L, Pastore RA, Bergin JJ. Aplastic anemia following viral hepatitis. Medicine 1975; 54: 139-64.
15. Cattral MS, Langnas AN, Markin RS, et al. Aplastic anemia after liver transplantation for fulminant liver failure. Hepatology 1994; 20: 813-8.
16. Socié G, Henry-Amar M, Bacigalupo A, et al. Malignant tumors occurring after treatment of aplastic anemia. N Engl J Med 1993; 329: 1152-7.
17. Frickhofen N, for the German Aplastic Study Group: Antithymocyte globulin and methylprednisolone with or without cyclosporin A for the treatment of aplastic anemia. In: Ragavashar A, Schrezenmeier H, Frickhofen N, eds. Aplastic anemia: current perspectives on the pathogenesis and treatment. Wien, Austria: Blackwell-MZV,: 118.
18. Bacigalupo A, Hows, J, Gluckman E, et al. Bone marrow transplantation versus immunosuppression for the treatment of severe aplastic anemia: a report of the EBMT SAA Working Party. Br J Haematol 1988; 70: 177-82.
19. Nissen C, Gratwohl A, Tichelli A, et al. Gender and response to antilymphocyte globulin for severe aplastic anaemia. Br J Haematol 1992; 83: 319-25.
20. Tichelli A, Gratwohl A, Wursch A, et al. Late haematological complications in severe aplastic anemia. Br J Haematol 1988; 69: 413-8.